Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:39 PM
Ignite Modification Date:
2025-12-24 @ 2:39 PM
NCT ID:
NCT00813059
Eligibility Criteria:
Inclusion Criteria:
* Patients with newly diagnosed NAION (within the past 30 days but preferably within the first 14).
Exclusion Criteria:
* Patients who are unable to give informed consent
* Patient with:
* uncontrolled glaucoma
* pregnancy
* lactation
* proliferative diabetic retinopathy
* active clinically significant diabetic macular edema
* active uveitis
* prior treatment with intraocular steroids that incited significant increase in intra-ocular pressure
* other known causes of decreased visual acuity in the recently involved eye such as significant dry or wet macular degeneration
* previous history of other optic neuropathies
* previous history of ocular trauma that resulted in decreased visual acuity
* Patients with baseline amblyopia in the newly involved eye and visual acuity worse than 20/50 prior to the onset of NAION
* Previous treatment for any ocular condition with any investigational drugs
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
30 Years
Study:
NCT00813059
Study Brief:
Protocol Section:
NCT00813059